Related Experiment Video
Updated: Jul 3, 2025
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.3K
MicroRNA Signatures for Pancreatic Cancer and Chronic Pancreatitis: Expression Profiling by NGS.
Nidhi Singh1, Imteyaz Ahmad Khan1, Safoora Rashid1
1From the Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences.
Pancreas
|February 12, 2024
Summary
Researchers identified unique microRNA (miRNA) profiles in pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) tissues. These distinct miRNA signatures may aid in early cancer detection and reveal new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) presents a significant mortality challenge due to limited early detection methods.
- Patients with chronic pancreatitis (CP) represent a high-risk demographic for developing pancreatic cancer.
Purpose of the Study:
- To investigate and compare the differential microRNA (miRNA) expression profiles in pancreatic tissues from PDAC patients, CP patients, and healthy controls.
- To identify potential diagnostic biomarkers and therapeutic targets based on miRNA expression patterns.
Main Methods:
- MicroRNAs were extracted from formalin-fixed paraffin-embedded pancreatic tissues of 22 PDAC patients, 18 CP patients, and 10 normal control cases.
- Next-generation sequencing was employed to identify known and novel miRNAs, followed by differential expression analysis, target prediction, and pathway enrichment analysis.
Main Results:
- 166 known and 17 novel miRNAs were exclusively identified in PDAC tissues; 106 known and 10 novel miRNAs were specific to CP tissues.
- Key pathways implicated in PDAC development, based on miRNA targets, include proteoglycans, Hippo signaling, adherens junction, and transforming growth factor-β signaling.
Conclusions:
- A distinct set of exclusive and differentially expressed miRNAs in PDAC and CP tissues holds potential for diagnostic applications.
- Further research into miRNA-target gene interactions in carcinogenesis could unveil novel therapeutic strategies for pancreatic cancer.
